TMEPAI for Diagnosis and Treatment of Breast Cancer

Tech ID:

UT Health San Antonio researchers have developed an assay that detects overexpression of TMEPAI, a potential biomarker for aggressive cancer growth and invasion in TNBC patients.  Dr. Saikumar’s team has identified compounds that inhibit the expression of TMEPAI and thus may represent therapeutic candidates to inhibit cancer proliferation and metastasis.  In vitro and in vivo preclinical studies with these agents have confirmed activity resulting in reduced expression of TMEPAI, elevated expression of TGF- β tumor suppressor signaling, decreased cancer cell proliferation, and increased cancer cell death. 

For information contact:
File Closed
Pothana Saikumar
Prajjal Singha
Patent Information: